Categories Uncategorized

Oregon State University Gets Federal Grant to Conduct Hemp Research

Despite being just a year old, the industrial hemp sector is rapidly gaining ground. The cash crop had been outlawed for decades before the 2018 Farm Bill removed it from the list of controlled substances. Under the legislation, farmers should grow and sell industrial hemp under state and tribal programs provided the crop had less than 0.3% THC (delta-9 tetrahydrocannabinol).

THC is the chemical responsible for the psychoactive high marijuana is famous for, and for hemp to be considered legal, it has to have minuscule levels of THC.

Although the sector is booming, with experts saying it will be worth billions by 2024, there’s startlingly little information on hemp. From genetics to planting practices, most of the players are playing it by ear. Oregon State University (OSU) has been among the leaders in hemp research, and the school recently received funding to help support its new Global Hemp Information Center.

An announcement from the office of U.S. Sen. Jeff Merkley stated that the federal government is allocating $2.5 million to the University to use on the new program. The funding was part of a larger federal spending bill.

“We were pleased to see the appropriation get approved as it shows the federal government’s confidence in our work,” says Allan Sams, Dean of the College of Agricultural Sciences OSU. He and other OSU officials introduced the hemp center back in June at the University’s North Willamette Research and Extension Center.

In the year since sales have been legal, demand for hemp has been at an all-time high. The plant itself is insanely versatile, said to have thousands of uses. A few of them include making fabric, bioplastics and a sturdy building material called hempcrete. Hemp seeds are quite nutritional too.

On top of that, the plant produces over 100 cannabinoids, including the infamous THC and cannabidiol (CBD). Unlike THC, cannabidiol isn’t psychoactive, but it has a ton of other uses. Said to be medically effective, it works against a variety of illnesses including anxiety and high blood pressure.

The university has dedicated more than 40 faculty members from 19 academic disciplines to hemp research, teaching and extension services, and it plans on directing all that expertise into the new Global Hemp Information Center.

Sams says the funds will support the establishment of the center. “The work will involve other universities and will foster collaborative research to support the development of this new industry.”

This research grant is likely to be seen as good news for hemp companies like SinglePoint Inc. (OTCQB: SING) and Green Hygienics Holdings Inc. (OTCQB: GRYN) who would like to see as much scientific information as possible available to all stakeholders.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing PsychedelicNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. PNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. PsychedelicNewsWire (PNW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have a questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic

The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE…

1 month ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

The new FDA voucher program aims to speed approval of drugs aligned with national health…

2 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage

The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…

2 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…

2 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…

3 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…

3 months ago